Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/222857
Scale-Agnostic Models Based on Dimensionless Quality by Design as Pharmaceutical Development Accelerator
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
This comprehensive review of the synergistic use of Quality by Design (QbD) and the Pi–
Buckingham theorem explores an innovative approach to enhancing product development
and process optimization within the pharmaceutical industry. QbD is a systematic, proactive methodology that integrates quality considerations throughout the product lifecycle to
ensure that pharmaceutical products meet regulatory standards for safety and efficacy from
the outset of development. The Pi–Buckingham theorem serves as a foundational principle
in dimensional analysis, facilitating the simplification of complex models by transforming
physical variables into dimensionless parameters. This synergy enables researchers to better understand and control the factors affecting critical quality attributes (CQAs), thereby
improving manufacturing outcomes and minimizing variability.
Keywords: Quality by Design; design space; Pi–Buckingham; dimensional analysis; design
of experiments; pharmaceutical process development
Matèries
Matèries (anglès)
Citació
Citació
ROMERO OBON, Miquel, SANCHO-OCHOA, Virginia, ROUAZ EL HAJOUI, Khadija, PÉREZ LOZANO, Pilar, SUÑÉ POU, Marc, SUÑÉ I NEGRE, Josep m. (josep maria), GARCÍA MONTOYA, Encarna. Scale-Agnostic Models Based on Dimensionless Quality by Design as Pharmaceutical Development Accelerator. _Pharmaceuticals_. 2025. Vol. 18, núm. 7. [consulta: 21 de gener de 2026]. ISSN: 1424-8247. [Disponible a: https://hdl.handle.net/2445/222857]